Intelligent Bio Solutions Inc (INBS)

$0.66 -0.01 (-1.58%)
Market Cap 6.34M
Revenue (ttm) 3.05M
Net Income (ttm) -10.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 1.92
Profit Margin -346.56%
Debt to Equity Ratio 0.00
Volume 55,000
Avg Vol 297,548
Day's Range N/A - N/A
Shares Out 9.45M
Stochastic %K 25%
Beta 4.49
Analysts Sell
Price Target $12.00

Company Profile

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 20...

Industry: Medical Devices
Sector: Healthcare
Phone: 646 828 8258
Website: ibs.inc
Address:
135 West, 41st Street, 5th Floor, New York, United States
Nikolinit
Nikolinit Nov. 28 at 10:26 AM
$INBS extremely bullish position 2-3 target buy outlook
0 · Reply
Finanz
Finanz Nov. 27 at 12:33 AM
$INBS NASDAQ requires a full 20 consecutive days over $1.00. Reverse split may be necessary...or go to the new Texas Exchange next year.
1 · Reply
Touji93
Touji93 Nov. 21 at 2:04 AM
$INBS GAME OVER☠️ Hey stupid friends, for the last two years you've been saying, "inbs is such a great tech company!!!" Today I saw the results of the last two years. I feel sorry for you guys when we're about to delist. 🥲 good bye
1 · Reply
Bocke
Bocke Nov. 20 at 1:52 PM
$INBS Uns ich nehme Teil an einer Gartenzaunkonferenz mit meinem Nachbarn. Yeaaah.
1 · Reply
newsfile_corp
newsfile_corp Nov. 20 at 1:32 PM
https://nfne.ws/275270 $INBS #Banking #FinancialServices #NASDAQ #Investing
0 · Reply
Bocke
Bocke Nov. 18 at 11:33 AM
0 · Reply
RaySan
RaySan Nov. 17 at 7:15 PM
$INBS Averaging down.
0 · Reply
SoldierOfGod
SoldierOfGod Nov. 16 at 6:31 PM
$INBS when is this going to bottom? Christmas? I can’t see this recovering until spring of next year.
1 · Reply
Dan_o
Dan_o Nov. 15 at 4:22 PM
$INBS An SC 13G/A, amended statement of ownership was just filed. Hedge fund Alyeska Investment Group now owns 10% of the outstanding shares.
0 · Reply
Profitfire
Profitfire Nov. 13 at 11:17 PM
$INBS almost 😅😉
0 · Reply
Latest News on INBS
Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025

Nov 20, 2025, 8:30 AM EST - 9 days ago

Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025

Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth

Nov 12, 2025, 8:30 AM EST - 17 days ago

Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth

Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year

Nov 4, 2025, 8:30 AM EST - 25 days ago

Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year

Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480

Oct 30, 2025, 8:30 AM EDT - 4 weeks ago

Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480

Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

Oct 23, 2025, 8:30 AM EDT - 5 weeks ago

Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance

Sep 26, 2025, 8:30 AM EDT - 2 months ago

Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance

Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System

Sep 17, 2025, 8:30 AM EDT - 2 months ago

Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

Aug 19, 2025, 8:30 AM EDT - 3 months ago

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Aug 15, 2025, 8:30 AM EDT - 3 months ago

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

Aug 12, 2025, 8:30 AM EDT - 3 months ago

Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Aug 7, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

Aug 6, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

Jul 30, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Jul 25, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

Jul 23, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority

Jul 16, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

Jul 15, 2025, 8:30 AM EDT - 4 months ago

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo

Jul 10, 2025, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo

Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Jun 25, 2025, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

Jun 18, 2025, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

Jun 11, 2025, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

May 22, 2025, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

May 19, 2025, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing

May 15, 2025, 9:00 AM EDT - 7 months ago

Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing

Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

May 13, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion

May 6, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

Apr 22, 2025, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Mar 31, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

Mar 28, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

Mar 27, 2025, 9:00 AM EDT - 8 months ago

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Mar 26, 2025, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch

Mar 25, 2025, 9:00 AM EDT - 8 months ago

Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Mar 20, 2025, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

Mar 11, 2025, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock

Feb 21, 2025, 4:05 PM EST - 10 months ago

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

Feb 20, 2025, 8:30 AM EST - 10 months ago

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

Feb 19, 2025, 4:42 PM EST - 10 months ago

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

Feb 13, 2025, 8:30 AM EST - 10 months ago

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Feb 10, 2025, 8:30 AM EST - 10 months ago

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

Feb 7, 2025, 8:30 AM EST - 10 months ago

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

Feb 6, 2025, 9:00 AM EST - 10 months ago

Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Jan 31, 2025, 9:00 AM EST - 10 months ago

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Jan 29, 2025, 9:00 AM EST - 10 months ago

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites

Jan 14, 2025, 8:30 AM EST - 11 months ago

Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites

Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology

Dec 18, 2024, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET

Dec 4, 2024, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET

Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference

Nov 21, 2024, 8:30 AM EST - 1 year ago

Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results

Oct 29, 2024, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results

Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles

Nikolinit
Nikolinit Nov. 28 at 10:26 AM
$INBS extremely bullish position 2-3 target buy outlook
0 · Reply
Finanz
Finanz Nov. 27 at 12:33 AM
$INBS NASDAQ requires a full 20 consecutive days over $1.00. Reverse split may be necessary...or go to the new Texas Exchange next year.
1 · Reply
Touji93
Touji93 Nov. 21 at 2:04 AM
$INBS GAME OVER☠️ Hey stupid friends, for the last two years you've been saying, "inbs is such a great tech company!!!" Today I saw the results of the last two years. I feel sorry for you guys when we're about to delist. 🥲 good bye
1 · Reply
Bocke
Bocke Nov. 20 at 1:52 PM
$INBS Uns ich nehme Teil an einer Gartenzaunkonferenz mit meinem Nachbarn. Yeaaah.
1 · Reply
newsfile_corp
newsfile_corp Nov. 20 at 1:32 PM
https://nfne.ws/275270 $INBS #Banking #FinancialServices #NASDAQ #Investing
0 · Reply
Bocke
Bocke Nov. 18 at 11:33 AM
0 · Reply
RaySan
RaySan Nov. 17 at 7:15 PM
$INBS Averaging down.
0 · Reply
SoldierOfGod
SoldierOfGod Nov. 16 at 6:31 PM
$INBS when is this going to bottom? Christmas? I can’t see this recovering until spring of next year.
1 · Reply
Dan_o
Dan_o Nov. 15 at 4:22 PM
$INBS An SC 13G/A, amended statement of ownership was just filed. Hedge fund Alyeska Investment Group now owns 10% of the outstanding shares.
0 · Reply
Profitfire
Profitfire Nov. 13 at 11:17 PM
$INBS almost 😅😉
0 · Reply
jessedmo
jessedmo Nov. 12 at 2:02 PM
$INBS earnings looking better and better each quarter. Once FDA approval goes thru it will skyrocket.
0 · Reply
Bocke
Bocke Nov. 11 at 3:54 PM
$INBS Diese blöde Wichsfirma schafft es nicht einmal ihre Earnings zu veröffentlichen, geschweige denn von einer FDA-Zulassung. Reine Spekulation bei diesem Miststück.
0 · Reply
Bocke
Bocke Nov. 11 at 3:43 PM
$INBS Quartalsergebnisse: 6.11.2025, dann gar nichts. Gestern 10.11.: • Intelligent Bio Solutions (NASDAQ: INBS ) wird voraussichtlich die Ergebnisse des ersten Quartals veröffentlichen. Heute ist der 11.11. ! Immer noch NICHTS ! Warum ?????????
2 · Reply
Bocke
Bocke Nov. 11 at 3:37 PM
$INBS Warum können sie nicht ein mal die Quartalsergebnisse zum Angegebenen Zeitpunkt veröffentlichen? Was steckt dahinter? Wieso muss man bei dieser Geschäftsführung immer auf Alles warten? Warum lügen sie dauernd?
0 · Reply
Bocke
Bocke Nov. 10 at 3:12 PM
$INBS Erst mal durch die 0,83.....dann geht es rauf zu 1,0
0 · Reply
ymg200
ymg200 Nov. 6 at 9:54 PM
$INBS Again, why is it down by that much? It still waits for approval, correct?
3 · Reply
Profitfire
Profitfire Nov. 6 at 3:01 PM
$INBS CEO 😂👇 statement Thanks I’m out here 😇
2 · Reply
ItsCash
ItsCash Nov. 5 at 10:47 PM
$INBS taking a 👃🏼🤿 unfortunate 😳
0 · Reply
smoothiron
smoothiron Nov. 5 at 1:06 PM
$INBS😎🥃🥃🥃
0 · Reply
dbr_island
dbr_island Nov. 4 at 9:27 PM
$CSAI read what I said below👇💰💰💰 SCNX adding before they take this back to $1+ and beyond with their 2 FDA approved products ready to be commercialized $MSAI $CMBM $INBS $WORX lets get it
0 · Reply
louter_genieten
louter_genieten Nov. 4 at 7:33 PM
$INBS averaged down with buy in $0.88
1 · Reply
Hpkmd01
Hpkmd01 Nov. 4 at 6:14 PM
$INBS Amazing how cheap its SP currently is. Fundamentals are strong as reflected in today’s revenue announcement. Entry into US market delayed for reasonable reasons. Congrats to those getting into INBS so cheaply. My own average cost is $1.39, but I’m holding firm not investing more. Reverse split not needed unless under $1 for 6 months (hopefully no MULN repeat). FDA approval should be positive news before then.
0 · Reply